Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, announces it has acquired ANiGENT, LLC, a software company focused on delivering drug diversion detection through a proprietary intelligence platform. The acquisition is expected to add important drug diversion surveillance and monitoring capabilities to Omnicell’s portfolio of outcomes-centric medication management solutions, that are designed to enable compliance and foster a culture of transparency.
Read the full article: Omnicell Acquires ANiGENT //
Source: https://www.omnicell.com/resources/news/omnicell-acquires-anigent/